title: Expanding noninvasive prenatal testing to include microdeletions and segmental aneuploidy: cause for concern?
authors.affiliation: Combimatrix Molecular Diagnostics, Irvine, California, USA.
authors.forename: Trilochan
authors.initials: T
authors.lastname: Sahoo
authors.affiliation: Combimatrix Molecular Diagnostics, Irvine, California, USA.
authors.forename: Karine
authors.initials: K
authors.lastname: Hovanes
authors.affiliation: Combimatrix Molecular Diagnostics, Irvine, California, USA.
authors.forename: Michelle N
authors.initials: MN
authors.lastname: Strecker
authors.affiliation: Combimatrix Molecular Diagnostics, Irvine, California, USA.
authors.forename: Natasa
authors.initials: N
authors.lastname: Dzidic
authors.affiliation: Combimatrix Molecular Diagnostics, Irvine, California, USA.
authors.forename: Sara
authors.initials: S
authors.lastname: Commander
authors.affiliation: Combimatrix Molecular Diagnostics, Irvine, California, USA.
authors.forename: Mary K
authors.initials: MK
authors.lastname: Travis
mesh_terms: D002872:Chromosome Deletion; D004247:DNA / Q000097:blood*; D005260:Female; D005820:Genetic Testing; D006801:Humans; D011247:Pregnancy; D011296:Prenatal Diagnosis
chemical_list: D004247:DNA